Skip to main content

Table 3 The association between ABC goal achievement of diabetes, and clinical and demographic characteristics of patients

From: The association between advanced glycation end products (AGEs) and ABC (hemoglobin A1C, blood pressure, and low-density lipoprotein cholesterol) control parameters among patients with type 2 diabetes mellitus

Variables

Number of ABC goals achieved

No

One

Two

Three

P-value

Age (years)

58.98 ± 9.3

54.39 ± 9.9

53.99 ± 9.7

52.44 ± 10.2

0.003*

Sex

 Female

19.2%

36.7%

33.3%

10.7%

0.148

 Male

28.4%

37.1%

29.3%

5.2%

Duration of T2D (years)

8.46 ± 5.9

6.93 ± 5.6

7.72 ± 6.4

6.12 ± 4.5

0.234

FBS (mg/dL)

197.9 ± 63

194.5 ± 67

173.9 ± 55

156.8 ± 32

0.002*

HbA1C (%)

8.8 ± 2.0

8.4 ± 1.3

7.7 ± 1.8

6.2 ± 0.5

0.001*

SBP (mmHg)

133.94 ± 21.9

129.36 ± 20.6

119.26 ± 14.7

112.12 ± 10.5

0.001*

DBP (mmHg)

80.79 ± 10.7

79.45 ± 10.4

74.94 ± 10.3

73.48 ± 7.1

0.001*

Cholesterol (mg/dL)

210.26 ± 39

198.41 ± 43

175.65 ± 36

157.56 ± 27

0.001*

Triglycerides (mg/dL)

171.53 ± 72

168.60 ± 82

161.61 ± 79

166.04 ± 98

0.880

LDL (mg/dL)

138.98 ± 25

112.64 ± 31

97.39 ± 29

81 ± 13

0.001*

HDL (mg/dL)

44.75 ± 9

45.39 ± 9

45.89 ± 10

45.08 ± 9

0.904

BMI (kg/m2)

26.56 ± 3.6

27.37 ± 3.9

28 ± 4.0

27.24 ± 3.8

0.155

AGEs (%)

78.42 ± 13.1

75.25 ± 12.9

72.17 ± 12.3

74.11 ± 10.4

0.023

Albuminuria (mg/day)

78.67 ± 15

74.86 ± 24

84.20 ± 28

78.38 ± 20

0.523

Treatment

 OHA

24.4%

36.7%

28.3%

10.6%

0.056

 Ins

22%

51.2%

26.8%

0.0%

 OHA + Ins

19.4%

29.2%

43.1%

8.3%

  1. T2D, Type 2 diabetes mellitus; FBS, Fasting blood sugar; HbA1C, hemoglobin A1c; SBP, Systolic blood pressure; DBP, Diastolic blood pressure; LDL, low-density lipoprotein; HDL, high-density lipoprotein; BMI; Body mass index; AGEs, advanced glycation end-products; OHA, Oral hypoglycemic agents; Ins, Insulin
  2. *P < 0.05